Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer
Annals of oncology : official journal of the European Society for Medical Oncology (2006) - Comment
pubmed: 16807438  doi: 10.1093/annonc/mdj965  issn: 1569-8041  issn: 0923-7534 

J.T. Roberts, H. Von Der Maase, L. Sengeløv, P.F. Conte, L. Dogliotti, T. Oliver, M.J. Moore, A. Zimmermann, M. Arning